ST. LOUIS, June 18, 2019 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the first graduating class from its Robotic Electrophysiology Fellows Program. The Robotic Electrophysiology Fellows Program is designed to enhance the traditional electrophysiology fellowship […]
Rhythm
CardioFocus Launches 100th HeartLight® Center Worldwide
MARLBOROUGH, Mass., June 18, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the HeartLight® Endoscopic Ablation System is now offered at more than 100 hospitals worldwide. The HeartLight System is a revolutionary catheter ablation technology for controlled and consistent pulmonary vein isolation (PVI), the […]
Aurora Resurgence Announces Sale of Cardiac Science Corporation to ZOLL Medical Corporation
LOS ANGELES, June 11, 2019 /PRNewswire/ — Aurora Resurgence, a Los Angeles-based private equity firm, today announced that its affiliate has entered into a definitive agreement to sell Cardiac Science Corporation (“Cardiac Science” or “CSC”), a leading provider of automated external defibrillators (“AEDs”), related services and accessories, to ZOLL® Medical Corporation, an Asahi Kasei […]
Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the launch of and first patient prescription for the ZOLL µCor™ (pronounced “Micro Core”) Heart Failure and Arrhythmia Management System (HFAMS), designed to help clinicians improve outcomes and reduce hospitalizations for […]
BioSig Allowed a U.S. Patent for PURE EP™ Simulator
Santa Monica, CA, June 06, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the U.S. Patent & Trademark Office allowed a U.S. patent application covering its […]
Bardy Diagnostics™ Selected as Winner of the MedTech Breakthrough Award For Best New Diagnostic Technology
SEATTLE, June 6, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has recognized the Carnation Ambulatory Monitor (CAM™) with the […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center opening new Electrophysiology Center
AUSTIN, Texas, June 4, 2019 /PRNewswire/ — The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is opening a new, state-of-the-art Electrophysiology Center dedicated to treating patients with cardiac arrhythmias. The new Electrophysiology Center is set to open at the end of the month. “This expansion at the Texas Cardiac Arrhythmia Institute […]
touchCARDIO Joins Forces with Arrhythmia Alliance
LONDON, June 5, 2019 /PRNewswire/ — This World Heart Rhythm Week (3-9 June 2019) Arrhythmia Alliance has announced a collaboration with touchCARDIO that will see the two join forces to further improve the diagnosis, treatment and quality of life for all those affected by arrhythmias. Arrhythmia Alliance World Heart Rhythm Week is an […]
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019
MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve Therapy Structural Heart Summit (TVT 2019), which will take place June 12-15 at the Sheraton Grand Chicago. The company’s Tempo® Temporary Pacing Lead will be featured in […]
Medtronic Gains U.S. FDA Clearance for New Catheter System for HIS Bundle Pacing
DUBLIN – May 29, 2019 – Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) clearance and commercial launch for the SelectSite(TM) C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing (HBP). The SelectSite C304-HIS deflectable catheter system features a deflectable, out-of-plane curve to reach the bundle […]



